ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Diagnostic accuracy of 18F-PSMA-1007 PET/CT for prostate 18 cancer in primary staging and biochemical recurrence with different serum PSA levels: A systematic review and meta- analysis

Liu, Xue; Wang, Qi; Zhang, Bao; Jiang, Tao*; Zeng, Wenbing*univ three gorges; jishou univ
Hellenic Journal of Nuclear Medicine2022-1
4被引12阅读
引用收藏
分享

摘要

Objective: We performed a systematic review and meta-analysis to evaluate the application value of flu-orine-18-prostate specific membrane antigen (F-18-PSMA-1007) positron emission tomography/computed to-mography (PET/CT) in patients with different serum prostate specific antigen (PSA) levels and primary pros-tate cancer (PCa) or the biochemical recurrence of Pca. Methods: A comprehensive electronic literature se-arch of the PubMed, Embase and Cochrane Library databases was conducted in accordance with the PRISMA statement. We calculated the pooled sensitivity and specificity of F-PSMA-1007 PET/CT in PCa. A summary 18 receiver operator characteristic (SROC) curve and the area under the curve (AUC) were used to assess the accuracy of F-18-PSMA-1007 PET/CT for PCa. Results: The final analysis included 11 studies that described 799 18 patients and 4261 lesions with F-18-PSMA-1007 PET/CT in PCa. The pooled sensitivity and specificity of F-18-PS -18 18 MA-1007 PET/CT in PCa were 0.836 and 0.946, respectively. The per-patient pooled sensitivity and specificity of F-PSMA-1007 PET/CT in PCa were 0.934 and 0.453, and the per-lesion values were 0.816 and 0.979, res -18 pectively. The pooled sensitivity and specificity of F-PSMA-1007 PET/CT in PCa with PSA>2ng/mL were 18 0.923 and 0.442 in a patient-based analysis and 0.799 and 0.961 in a lesion-based analysis, respectively. The pooled sensitivity and specificity of F-18-PSMA-1007 PET/CT in PCa with PSA<2ng/mL were 0.832 and 0.277 in 18 a patient-based analysis, respectively. Conclusion: This meta-analysis showed that F-PSMA-1007 PET/CT 18 has a higher diagnostic value for prostate cancer in the setting of primary PCa and biochemical recurrence. As serum PSA levels increase, the diagnostic accuracy of F-18-PSMA-1007 PET/CT also improves. 18

学科与关键词

关键词
Prostate cancerBiochemical recurrenceF-18-PSMA-1007Meta-analysisPET
相关
加载中…
  • Diagnostic value of integrated 18F-PSMA-1007 PET/MRI compared with that of biparametric MRI for the detection of prostate cancer
    Zeng, Yuping; Leng, Xiaoming; Liao, Hengbin; Jiang, Guihua*; Chen, Ping*Prostate International, 2022, 10(2): 108-116.被引 3
  • The Role of PET-CT Imaging in Prostate Cancer
    Subesinghe, Manil*; Kulkarni, Meghana; Cook, Gary J.SEMINARS IN ULTRASOUND CT AND MRI, 2020, 41(4): 373-391.被引 2
  • Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis
    Hu, Yuan; Wang, Peng; Dai, Wenli*BMC Pulmonary Medicine, 2023, 23(1): 73.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Hellenic Journal of Nuclear Medicine
发表日期
2022-01
卷期
第 25 卷, 第 1 期
页码
88-102
语言
ENGLISH
期刊等级
4区
成果收录
SCIE

作者

  • L

    Liu, Xue (第一作者)

    univ three gorges

  • W

    Wang, Qi

    jishou univ

查看全部 5 位作者收起作者
  • Z

    Zhang, Bao

  • J

    Jiang, Tao (通讯)

  • Z

    Zeng, Wenbing (通讯)

    univ three gorges

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417